Literature DB >> 9207276

Bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro.

T L Mynott1, S Guandalini, F Raimondi, A Fasano.   

Abstract

BACKGROUND & AIMS: Diarrhea is a major cause of illness and death in children and young animals. The aim of this study was to investigate the possible therapeutic effect of bromelain, a proteolytic extract obtained from pineapple stems on bacterial toxin and second-messenger agonist-induced intestinal secretion.
METHODS: The effect of bromelain pretreatment on short-circuit responses to Escherichia coli heat-labile enterotoxin, heat-stable enterotoxin, and Vibrio cholerae cholera toxin was evaluated in rabbit ileum mounted in Ussing chambers.
RESULTS: Bromelain was 62% effective in preventing heat-labile enterotoxin-induced secretion, 51% effective against cholera toxin, and 35% effective against heat-stable enterotoxin [corrected]. Bromelain also prevented secretory changes caused by prostaglandin E2, theophylline, calcium-ionophore A23187, 8-bromoadenosine 3':5'-cyclic monophosphate, and 8-bromoguanosine 3':5'-cyclic monophosphate, well-known intracellular mediators of ion secretion. The efficacy of bromelain was not caused by reduced tissue viability resulting from its proteolytic effects on enterocytes, indicated by experiments measuring uptakes of nutrients into intestinal cells and experiments measuring short-circuit responses to glucose.
CONCLUSIONS: Bromelain prevents intestinal fluid secretion mediated by secretagogues that act via adenosine 3':5'-cyclic monophosphate, guanosine 3':5'-cyclic monophosphate, and calcium-dependent signaling cascades. It may be clinically useful as an antidiarrheal drug.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207276     DOI: 10.1016/s0016-5085(97)70093-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Bromelain protects piglets from diarrhoea caused by oral challenge with K88 positive enterotoxigenic Escherichia coli.

Authors:  D S Chandler; T L Mynott
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

2.  Effect of bromelain on milk yield, milk composition and mammary health in dairy goats.

Authors:  A Contreras; M J Paape; R H Miller; J C Corrales; C Luengo; A Sánchez
Journal:  Trop Anim Health Prod       Date:  2008-07-27       Impact factor: 1.559

3.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

4.  Proteolytic inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells.

Authors:  Tracey L Mynott; Ben Crossett; S Radhika Prathalingam
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Bromelain's penetration into the blood and sinonasal mucosa in patients with chronic rhinosinusitis.

Authors:  D Passali; G C Passali; L M Bellussi; C Sarafoleanu; M Loglisci; C Manea; C Iosif; F M Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-06       Impact factor: 2.124

6.  In vitro Evaluation of Antibacterial Efficacy of Pineapple Extract (Bromelain) on Periodontal Pathogens.

Authors:  N C Praveen; A Rajesh; Manish Madan; Vishwajit Rampratap Chaurasia; Neel V Hiremath; Akanksha Manmohan Sharma
Journal:  J Int Oral Health       Date:  2014-09

7.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10

Review 8.  Beneficial Properties of Bromelain.

Authors:  Pawel Hikisz; Joanna Bernasinska-Slomczewska
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.